Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (ticker: HSAQ) is a healthcare-focused SPAC sponsored by Health Sciences Holdings, LLC that completed its initial public offering in 2021 targeting the life sciences and medical device sector. The January 2023 8-K filing marks a key milestone in the company's de-SPAC process, reflecting Orchestra BioMed's path to becoming a publicly traded bioelectronic medicine company developing therapies for cardiovascular and autonomic conditions. Following the business combination, the combined entity began trading under the ticker OBIO on Nasdaq. For comprehensive filing history, deal timelines, sponsor backgrounds, and real-time SPAC analytics on Orchestra BioMed and hundreds of other transactions, sign up for full data access at SpacDesk.